Novo Nordisk’s new weight-loss drug works better, but not as well as expected
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.
What's Your Reaction?







Chatty News Dec 7, 2024 0 38
Chatty News Nov 18, 2024 0 35
Chatty News Nov 20, 2024 0 31
Chatty News Nov 26, 2024 0 31
Chatty News Dec 26, 2024 0 28
Chatty News Nov 18, 2024 0 18
Chatty News Nov 18, 2024 0 20
Chatty News Nov 18, 2024 0 20
Total Vote: 5
Yes